The effect of fecal microbiota transplantation on antibiotic-associated diarrhea and its impact on gut microbiota

Background Antibiotic-associated diarrhea (AAD) refers to symptoms of diarrhea that cannot be explained by other causes after the use of antibiotics.

AAD is thought to be caused by a disruption of intestinal ecology due to antibiotics.

Fecal Microbiota Transplantation (FMT) is a treatment method that involves transferring microbial communities from the feces of healthy individuals into the patient’s gut.

Method We selected 23 AAD patients who received FMT treatment in our department.

Before FMT, we documented patients’ bowel movement frequency, abdominal symptoms, routine blood tests, and inflammatory markers, and collected fecal samples for 16S rRNA sequencing to observe changes in the intestinal microbiota.

Patients’ treatment outcomes were followed up 1 month and 3 months after FMT.

Results Out of the 23 AAD patients, 19 showed a clinical response to FMT with alleviation of abdominal symptoms.

Among them, 82.61% (19/23) experienced relief from diarrhea, 65% (13/20) from abdominal pain, 77.78% (14/18) from abdominal distension, and 57.14% (4/7) from bloody stools within 1 month after FMT.

Inflammatory markers IL-8 and CRP significantly decreased after FMT, but there were no noticeable changes in WBC, IL-6, and TNF-α before and after transplantation.

After FMT, the abundance of Bacteroides and Faecalibacterium increased in patients’ fecal samples, while the abundance of Escherichia-Shigella and Veillonella decreased.

Conclusion FMT has a certain therapeutic effect on AAD, and can alleviate abdominal symptoms and change the intestinal microbiota of patients.